InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-21.6%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by SNODGRASS H. RALPH. Officer active across 1 company, notably VistaGen Therapeutics, Inc.. Cumulatively, 8 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €17k. History available since 30 June 2021. The latest transaction was disclosed on 31 December 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations8 total
3,623 shares@ US$1.65750.021% mcap13.5% of flowCommon StockSEC:0001415889-22-000038:0
3,623 shares@ US$1.657513.5% of flowCommon StockSEC:0001415889-22-000038
740 shares0Common StockSEC:0001415889-21-004226:0
740 shares0Common StockSEC:0001415889-21-004226
▲
3,750 shares@ US$2.7322.3% of flowCommon StockSEC:0001415889-21-004002
Ideal exit: 14 May 2022 (T+270)
▲
3,750 shares@ US$2.730.035% mcap22.3% of flowCommon StockSEC:0001415889-21-004002:0
Ideal exit: 14 May 2022 (T+270)
3,391 shares@ US$1.946514.2% of flowCommon StockSEC:0001415889-21-003389
3,391 shares@ US$1.94650.022% mcap14.2% of flowCommon StockSEC:0001415889-21-003389:0
8 of 8 declarations
About SNODGRASS H. RALPH
H. Ralph Snodgrass is a director at VistaGen Therapeutics, Inc.
